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Introduction. Use of complementary and alternative medicine (CAM) in cancer patients is increasingly acceptable worldwide, but
most of the studies were surveyed from developed countries. In this study, we evaluated the ﬁrst and large cohort of cancer patients
with CAM use in Thailand. Materials and Methods. A self-administered questionnaire was completed by 248 cancer patients
attending outpatient radiotherapy unit at Ramathibodi Hospital. Results. The prevalence of CAM use was 60.9%. The most frequ-
ently used CAM were dietary/vitamin supplements (56.9%). Independent predictors of CAM use were high income (P<0.001)
and cancer type (P = 0.019). About half of the patients (51%) reported positive eﬀects from CAM use. Nevertheless, 9.4% of the
patient also reported side eﬀects. The majority of patients (58.3%) did not disclose their use of CAM to their doctors because they
felt that it was not necessary for doctors to know (65.9%). The average spending for CAM use was 200USD/month (range, 10–
1,000). Conclusion. Although the cost for CAM is relatively expensive, the prevalence of CAM use in cancer patients in Thailand is
high particularly, in patients with higher income. Therefore, all clinical oncologists should be concerned about the use of CAM
during evaluation of the cancer patients.
1.Introduction
Cancer is the major cause of death in most countries
throughout the world. The main standard or conventional
therapies such as surgery, chemotherapy, radiotherapy, and
hormone therapy usually cause many adverse eﬀects. Com-
plementary and alternative medical (CAM) practices have
become increasingly popular worldwide and many cancer
patients have turned to CAM with hope of ﬁnding a
cure to their illness, as well as to make them feel better.
The National Center for Complementary and Alternative
Medicine (NCCAM) deﬁnes CAM as a group of diverse
medical and healthcare systems, practices, and products that
are not considered to be part of conventional medicine [1].
The prevalence of CAM use in cancer patients is frequently
high and estimated to be from 30% to 90% [2–7]. The up-
datesystematicreview[3]wasthesurveyedstudiespublished
from 18 countries in Australia, Canada, Europe, New
Zealand, and the United States. From this study, the com-
bined prevalence for current use of CAM in cancer patients
was 40%. The highest was in the United States and the
lowest in Italy and the Netherlands. This metaanalysis also
s u g g e s t e da ni n c r e a s ei nC A Mu s ef r o ma ne s t i m a t e d2 5 %
in the 1970s and 1980s to more than 32% in the 1990s and
to 49% after 2000. Nevertheless, most of studies for CAM
use in cancer patients usually came from western and deve-
loped countries. So far, very few studies have described the
use of CAM in developing countries. To date in South East
Asia including Thailand, the rate of CAM use among cancer
patients is unknown. The use of traditional herbs and reme-
dies in our country is, however, well known and relatively
common. We evaluated the ﬁrst and large cohort of cancer
patientswithCAMuseinThailand.UnderstandingCAMuse
among cancer patients may provide insight into the moti-
vations behind such use and, therefore, the degree to which
conventional medical care has not met the needs of cancer2 Evidence-Based Complementary and Alternative Medicine
patients. Thus, the aims of this study were to determine the
prevalence and pattern of CAM use, reason for using CAM,
the perceived eﬀectiveness as well as their communication
with doctors about its use.
2.MaterialsandMethods
The study design was a descriptive cross-sectional study con-
ducted at the radiotherapy outpatient clinic at Ramathibodi
Hospital, Bangkok, Thailand. It was approved by the Ethics
Committee on Human Experimentation of the hospital.
2.1. The Questionnaire. The questionnaire used in this study
was the newly developed self-administering questionnaire,
because currently there is no related and proper question-
naire developed in Thailand. After an extensive literature re-
views on CAM in cancer patients, the 21-item questionnaire
was developed on the basis of the standard questionnaire
development (see the appendix).
2.2. Study Subjects. All cancer patients attending the radio-
therapy outpatient clinic of Ramathibodi Hospital from 1
June to 30 July 2011 were recruited into the study. The inclu-
sion criteria were all of 18-year and older patients with diag-
nosis of cancer within 3 years, writing ability in Thai, and
willingness to participate in this study.
2.3. Data Collection. All patients who met the inclusion cri-
teria during study period were invited to participate. Infor-
mation about the research was given verbally to each patient;
those who gave consent then ﬁlled in the questionnaires. The
participants used 10–15 minutes to complete the question-
naire while they were waiting at the outpatient clinic to be
seen by their physicians. Physicians who were in any way in-
volved in the treatment of each patient were not present dur-
ing the administration of the questionnaire. On completion,
the patients either put the questionnaire in a box or handed
it to the researcher assistant.
2.4. Statistical Analysis. The demographic characteristic data
werecalculatedbydescriptivestatistics.Categoricaldatawere
described with frequency and percentage and compared by
using chi-square. Continuous data were reported with mean
and range and compared by using student’s t-test. All ana-
lyses were performed using SPSS software version 16.0.
3. Results
There were 248 cancer patients participating in this study.
One hundred and ﬁfty-one (60.9%) of the total participants
reported having used at least one CAM since their diagnosis
of cancer. Table 1 shows the demographic characteristics of
CAM users and non-CAM users. There were no signiﬁcant
diﬀerences in the proportion of CAM users by gender, age,
marital status, religion, education level, occupation, cancer
type, or cancer staging. There were, however, signiﬁcant dif-
ferences in the proportion of cancer patients using CAM by
incomeachievement(P = 0.001)andbythecancertype(P =
0.019). The patients with a higher income were more likely
Table 1: Patient characteristic of CAM users and non-CAM users.
Characteristics
CAM
users (%)
151 (60.9)
Non-CAM
user (%)
113 (39.1)
P value
Sex 0.254
Male 47 (56) 37 (44)
Female 104 (63.4) 60 (36.4)
Mean age 53.7yrs 54.3yrs 0.728
Marital status 0.155
Single 21 (63.6) 12 (36.4)
Married 100 (57.1) 75 (42.9)
Widowed/divorced 28 (73.7) 10 (26.3)
Education status 0.327
Primary school or lower 61 (55.4) 49 (44.6)
Secondary/vocational school 43 (65.2) 23 (34.8)
Bachelor or higher 46 (66.7) 23 (33.3)
Occupation 0.374
Unemployed/retired/housewife 61 (55.4) 49 (44.6)
Employee 28 (71.8) 11 (28.2)
Government oﬃcial 25 (71.4) 10 (28.6)
Business owner 18 (58.1) 13 (41.9)
Agriculturist 17 (56.7) 13 (43.3)
Income (USD/month) 0.001∗
Less than 166 38 (46.3) 44 (53.7)
167–333 32 (60.4) 21 (39.6)
334–666 40 (71.4) 16 (28.6)
More than 666 41 (71.9) 16 (28.1)
Cancer type 0.019∗
Breast 38 (61.29) 24 (38.71)
Genitourinary 36 (67.9) 17 (32.1)
Head and neck 31 (60.8) 20 (39.2)
Gastrointestinal 8 (34.8) 15 (65.2)
Lung 11 (78.6) 3 (21.4)
Brain 13 (86.7) 2 (13.3)
Others 7 (41.2) 10 (58.8)
Not know/uncertain 7 (53.8) 6 (46.2)
Cancer stage 0.761
Stage I 33 (58.9) 23 (41.1)
Stage II 40 (58.8) 28 (41.2)
Stage III 29 (51.8) 27 (48.2)
Stage IV 12 (50) 12 (50)
Do not know/uncertain 32 (86.5) 5 (13.5)
to use CAM than those with a lower income. With regard to
the cancer type, the highest prevalence rate of CAM use was
by those with malignant brain tumor, followed by those with
lung cancer, and those with genitourinary cancer. The low-
est rates of CAM use were observed in gastrointestinal cancer
patients. The CAM products/therapies that were used are
shown in Table 2. The most common CAM was dietary/vita-
minsupplementfollowedbydietaryadjustment,meditation,
herbal medicine, and massage, respectively.Evidence-Based Complementary and Alternative Medicine 3
Table 2: Types of complementary and alternative medicine used by
patients (n = 151).
Type Frequency (%)
Diet & nutrition
Food/vitamin supplement 86 (56.9)
Dietary adjustment 75 (49.7)
Vegetarian food 25 (16.6)
High dose vitamin C 14 (9.3)
Physical body/relaxation
Massage 34 (22.5)
Aromatherapy 23 (15.2)
Detoxiﬁcation 20 (13.3)
Electromagnetic therapy 4 (2.6)
Acupuncture 3 (2.0)
Mind-body
Meditation 64 (42.4)
Yoga 8 (5.3)
Tai chi 6 (4.0)
Yorae 5 (3.3)
Herbal medicine 47 (31.1)
Spiritual therapies 17 (11.3)
Most patients were using CAM because as they wanted to
counteract suﬀering symptoms from the cancer or medical
treatment (33.1%), to directly ﬁght the disease or decrease
thetumor(31.1%),toassistconventionaltreatment(25.2%),
to improve physical well-being (17.2%), to improve emo-
t i o n a lw e l l - b e i n go rp r o v i d eh o p e( 1 1 . 3 % ) ,a n da sw e l la st o
do everything possible to ﬁght the disease (3.3%).
About half of the patients reported positive eﬀects from
CAM use including good eﬀect (20%) and moderate eﬀect
(31.0%), while 10.3% of patients reported no eﬀect from
CAM use. Nevertheless, 38.6% of patients were uncertain
about their eﬀect. Fourteen patients (9.4%) reported side
eﬀects from the CAM therapy they had used, most of which
seemed to be related to ingesting herbs or minerals and
massage. These side eﬀects included decrease in appetite
(5 cases), diarrhea (3 cases), exhaustion (3 cases), nausea-
vomiting (2 cases), gastric discomfort (2 cases), constipation
(1 case), abnormal menstruation (1 case), and muscle sprain
(1 case). Moreover, two patients complained about the cost
of their CAM use.
The majority of CAM users (58.2%) did not disclose the
use of CAM to their medical doctors, the most common
reasonswerethatitwasnotnecessaryforthedoctorstoknow
(65.9%), or the doctors never asked (40.9%) or the doctors
would disapprove of it (33.0%). Sixty-three patients (41.7%)
had told their doctors that they were using CAM. 39.7% of
doctors responded favorably, 33.3% of doctors were against
it, and 27% of doctors did not oﬀer any opinion about CAM
uses. Reasons for disclosure of CAM use to their doctors
were “the doctor asked” (37.1%), “the doctor should know”
(20.5%), and “wanted to know doctor’s opinion about CAM
use” (2.0%).
Patients were asked how much on average they spent on
CAM in one month. Only 58 out of 151 patients repor-
ted expenses (38.4%). The average spending was 200USD/
month, (with the range of 10–1,000). However, 3 patients re-
portedthattheyusedherbalmedicinewhichtheyplantedfor
their own use; therefore, they had no expenditure for CAM.
Likewise, one patient had relatives massage for him and had
no expenditure.
4. Discussion
To our knowledge, this is the ﬁrst study of the use of CAM by
patients with a variety of cancers in Thailand, and it is one
of the few representative studies available about the use of
CAM in cancer patient in Asia. The use of CAM by cancer
patients is very common and varies widely among popu-
lations. The update systematic review from Horneber et al.
[3] that surveyed a total of 152 studies from 18 countries in
the western world such as Australia, Canada, Europe, New
Zealand, and the United States reported that the prevalence
forcurrentuseofCAMacrossallstudieswas40%.Regarding
the prevalence of CAM use in Asian countries, there is very
few study reports, but the prevalence of CAM use seems
to be higher than that from the western countries. For the
example, the prevalence of CAM use ranged from 54% to
61%inTurkey[4,8],64%inMalaysia[5],60.9%inPalestine
[9], 55% in Singapore [10], and 93.4% in China [11]. The
rate of 60.9% that we found in this study is quite similar
with the papers from Asian countries but higher than that
of the study from Western countries. The higher prevalence
rate in our study and in Asian countries may be explained by
multiple factors such as traditional culture, religious beliefs,
the cost of conventional treatment or the methodology, and
the instrument used to collect the data. Sociodemographic
factors that appear to be related to CAM use are younger age,
higher education, higher income, married status, involve-
ment in a support group, and health insurance [12]. In the
present study, it was found that people from higher income
used CAM more frequently. It was also interesting to see
the prevalence rates of CAM use among diﬀerent cancer
types and stages. Despite suggestions from the literature that
CAMapplicationsweresigniﬁcantlyhigherinthegroupwith
advanced diseases and recurrent diseases [13], the present
study showed that brain and lung cancer patients used CAM
therapies signiﬁcantly more often than any other cancer
types. The possibility of the higher prevalence in both cancer
types might be because both of these diagnostic categories
are characterised by poor prognosis and a rapid physical dec-
line, often with metastasis present, and such patients may
have little hope from conventional treatments, thus turning
to CAM as an additional intervention to improve their lives.
T h er o l eo fC A Mm a yb ei m p o r t a n t ,n o to n l yb e c a u s ei ti n -
creases hope and optimism, but also improves quality of life
and helps manage symptoms, especially in terminal illness;
however relevant data in cancer patients are almost nonex-
istent to date. However, some of the results in this subgroup
analysis should be viewed with caution, as only a small num-
ber of patients participated in some of the diagnostic cate-
gories.4 Evidence-Based Complementary and Alternative Medicine
There are many types of CAM use worldwide. The most
popular CAM uses were dietary supplements, herbs and
botanicals, and relaxation techniques/meditation [2, 12, 14,
15]. In our surveyed population, the most frequently used
CAM was dietary and vitamin supplement, followed by die-
tary adjustment. The choice of the speciﬁc CAM treatment
used is based primarily on individual patient complaints
and problems, which may explain the discrepancies among
the studies. Furthermore, the stage of the cancer and the
approval of the patient’s physician may contribute to deter-
mining the type of CAM preferred by the patient. In cases
of advanced cancer, spiritual or relaxation therapies may be
the most appropriate complementary treatments, whereas
homeopathy or acupuncture may be the more popular treat-
ments of choice in earlier stages of cancer or in other chronic
diseases. Additional parameters that may aﬀect treatment
choice are diﬀerent cultural norms, backgrounds, and reli-
gious beliefs.
The major expectation of the patients in this study was
“counteract suﬀering symptoms from the disease or medical
treatment.” Since many of these therapies used are “comple-
mentary” in nature (such as aromatherapy, massage, med-
itation, and others), we may not need to prove their eﬀec-
tiveness before using them. As patients are demanding such
therapies, they are low-risk therapies and patients feel good
after their use. Such therapies may have a great role to play,
especially in the palliative care setting, where the goal is not
cure but rather improvement in quality of life. Patient satis-
faction can be an appropriate end point outcome for evalua-
tion in this setting rather than clinical outcome.
For the positive and negative eﬀects from its use, half of
the patients seemed to be satisﬁed with the use of CAM, for
they reported good or moderate beneﬁt from it. A wide
range of reasons may contribute to the use of CAM, and per-
haps the concept of “hope” is fundamental in each one of
these reasons. More than 30% of the patients used CAM the-
rapies to directly ﬁght the cancer or to decrease the tumor
burden. It is interesting to see that <5% of the patients used
CAM following the recommendation of their physician.
These ﬁndings coincide with ﬁndings from the other previ-
o u ss t u d i e s[ 5–7, 16–19] and perhaps are reﬂecting the dis-
approval of CAM therapies by the medical community or
the lack of information within the medical community
about available and eﬀective CAM therapies. Most patients
reported no adverse reactions to CAM. However, the poten-
tial for harmful drug: CAM product interactions exists.
There was a report showing that the use of CAM is also asso-
ciated with a signiﬁcant delay in cancer treatment [20].
Almost 60% of cancer patients who used CAM since the
diagnosis of cancer did not disclose the use of their CAM
therapies to their doctors. The main reasons for nondisclo-
sure were: “It was not necessary for the doctor to know,” 41%
ofpatientsreportedthat“theirdoctorsdidnotask,”andone-
third of the patients feared disapproval from their doctors.
Theseﬁndingsareconsistentwiththoseofotherinvestigators
[5–7, 16–19].
In our survey, when patients consulted their doctors,
almost 40% of them were told that they were free to continue
using CAM but one-third of the patients were told to stop.
These ﬁgures were also similar to the results in a previous
study of clinical oncologists [21]. It appears that a diﬃcult
situation for many oncologists emerges because of their lack
of scientiﬁc information on CAM. However, physicians
should acknowledge that 40.9% of patients did not inform
their physicians of their CAM use because their doctors did
notaskthem.Theseresultsindicatethatbetterpatient-physi-
ciancommunicationandmorereliableinformationonCAM
products are needed.
It has been suggested that poor communication between
physicians and cancer patients might lead to patients’ dissat-
isfaction. Thus, these patients are more likely to seek alter-
native methods for their treatment outside the conventional
treatment. In other words, it is argued that if patients could
better communicate with their care physicians, then it would
be possible to receive enough information on the progress of
theirdiseaseandtreatment,andthereforetherewouldnotbe
a ground for seeking alternative methods, or if they still felt
it were necessary, they would consult with their physicians
about the risks and beneﬁts of complementary therapies.
5. Conclusion
CAM use is common among cancer patients on treatment
with radiation therapy in Thailand. The patients with a
higherincomeweremorelikelytouseCAMthanthosewitha
lower income. However, the expense of CAM use is relatively
expensive when compared to their income. Most of the pa-
tients expect to be improved from suﬀering symptoms of
cancer and medical treatment, but only half of the patients
experiencedthebeneﬁtofCAM.Themajorityofpatientsdid
not disclose their use of CAM to their doctors because they
feltthatitwasnotnecessaryfordoctorstoknow.Thisﬁnding
mightsuggestthatthereweresomecommunicationgapsbet-
ween the clinicians and their patients. We recommend that
all clinical oncologists should be concerned and ask every
patient about the use of CAM as a routine practice.
Appendix
I.D.........
Please indicate your answers in the spaces provide below.
(If you do not want to answer a question, please leave it blank)
(1) Diagnosis
 Liver cancer
 Lung cancer
 Skin cancer
 Lymphoma
 Brain cancer
 Breast cancer
 Gastric cancer
 Esophageal cancer
 Colorectal cancer
 Uterine cancer
 Cervical cancer
 Prostate cancer
 Head and neck cancer
 Nasopharyngeal cancer
 Laryngeal cancerEvidence-Based Complementary and Alternative Medicine 5
 Bladder cancer
 Bone cancer
 I do not know
 Other (please specify)..............
(2) Stage of cancer
 (1)
 (2)
 (3)
 (4)
 (5) I don’t know
(3) Age, yr...................
(4) Sex
 (1) Male
 (2) Female
(5) Highest level of education completed
 (1) None
 (2) Primary school
 (3) High school
 (4) College
 (5) Professional degree
 (6) Other (please specify).............................
(6) What is your religion?
 (1) Bhudism
 (2) Muslim
 (3) Christian
 (4) Other (please specify)..................
(7) Marital status
 (1) Single
 (2) Married
 (3) Widowed/divorced
(8) Employment status
 (1) Employed (full time)
 (2) Employed (part time)
 (3) Employed but on medical leave/disability
 (4) Self-employed
 (5) Other (please specify).................
(9) What is your monthly income?
 (1) No income
 (2) Less than 1,500 USD
 (3) 1500–3500 USD
 (4) 3500–7000 USD
 (5) 7000–10000 USD
 (6) 10000 USD
(10) What treatment have you had for your cancer?
 (1) Chemotherapy
 (2) Radiation therapy
 (3) Surgery
 (4) Biological or targeted therapy
(11) Do you currently use any supplements or alternative
therapies or have you used these in the past
 (1) Yes (then proceed to question 12)
 (2) No
(12) Please check all that you currently use or have you used
these in the past (please check all that apply)
 (1) Food/vitamin supplement
 (2) Dietary adjustment
 (3) High dose vitamin C
 (4) Vegetarian diet
 (5) Detoxiﬁcation
 (6) Acupuncture
 (7) Massage
 (8) Aromatherapy
 (9) Electromagnetic therapy
 (10) Spiritual therapies
 (11) Herbal medicine
 (12) Meditation
 (13) Tai chi
 (14) Yoga
 (15) Yorae
 (16) Other (please specify)..............
(13) How did you learn about these supplements or
alternative therapy? (check all apply)
 (1) Family members
 (2) Friends
 (3) Personal knowledge
 (4) Doctor
 (5) Books/Magazines/TV/Radio
 ( 6 )O t h e rc a n c e rp a t i e n t s
 (7) Other (please specify).................
(14) When using these supplements or alternative therapies,
have they beneﬁted you?
 (1) No eﬀect
 (2) Good eﬀect
 (3) Moderate eﬀect
 (4) Uncertain
(15) When using these supplements or alternative therapies,
have you experienced unpleasant side eﬀects?
 (1) Yes, specify..........................
 (2) No
 (3) Uncertain
(16) About how much money have you spent on
supplementsoralternativetherapies?..........USD/month
(17) Have you told your doctor about these supplements or
alternative therapies?
 (1) Yes because
 (1.1) Doctor asked
 (1.2) Doctor should know
 (1.3) Wanted to know the doctor’s opinion
 (1.4) Other (please specify)...............................
 (2) No because
 (2.1) Doctor did not ask
 (2.2) It was not necessary for doctor to know
 (2.3) Doctor would disapprove
 (2.4) Other (please specify)....................................
(18) If you told your doctor, what was his/her reaction?
(check all apply)
 (1) Doctor in favor
 (2) Doctor opposed
 (3) Doctor do not oﬀer opinion
 (4) Other (please specify)....................
.....................
Thank you
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